Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CF Industries Holdings, Inc. (CF) vs Medpace Holdings Inc (MEDP) Price & Performance

CF Industries Holdings, Inc.Trade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

CF Industries Holdings, Inc. vs Medpace Holdings Inc — how do they compare? CF Industries Holdings, Inc. trades at $118.6 (market cap $18.31B), while Medpace Holdings Inc trades at $536.29 (market cap $15.31B). The key difference: CF Industries Holdings, Inc. is the larger of the two by market cap, and CF Industries Holdings, Inc. pays a 2.01% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.

CFMEDP
Market Cap
$18.31B$15.31B
Sector
Basic MaterialsTechnology
52-Week High
$137.55$620.59
52-Week Low
$76.08$308.88
Enterprise Value
$19.89B$14.78B
Dividend Yield
2.01%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CF Industries Holdings, Inc.

CF Industries stock trades at $120.92, up 3.42% today, with a bullish technical outlook and strong fundamentals. Recent earnings beats, a 20% dividend hike announced July 8, 2026, and robust profitability metrics like a 23.73% net margin support investor confidence. The stock is near consensus price targets, with moving averages signaling upward momentum.

The outlook is positive, driven by firm nitrogen demand and shareholder returns, but risks include input cost pressures and cyclical industry headwinds. Upside potential exists if earnings continue to exceed expectations, though overbought RSI levels suggest near-term consolidation may occur.

Medpace Holdings Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About CF Industries Holdings, Inc.

CF Industries is a leading producer and distributor of nitrogen fertilizers. The company operates seven nitrogen facilities in North America and holds joint venture interests in further production capacity in the United Kingdom and Trinidad and Tobago. CF makes nitrogen primarily using low-cost U.S. natural gas as its feedstock, making CF one of the lowest-cost nitrogen producers globally.

Read more on CF

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP